Random walks with thin filaments: application of in vitro motility assay to the study of actomyosin regulation

  • Steven Marston


The in vitro motility devised by Kron and Spudich (Kron and Spudich, 1986; Kron et al., 1991) has proved a very valuable technique for studying the motor properties of myosin of all kinds but it is equally useful for the study of the thin filaments of muscle and their regulation. The movement of a population of thin filaments over immobilised myosin appears to be random but it does in fact yield a large amount of information about contractility and its regulation. The key to extracting useful information from in vitro motility assay experiments is the logical and comprehensive analysis of filament movements.


Motility Assay Nemaline Myopathy Familial Hypertrophic Cardiomyopathy Muscle Tropomyosin Human Cardiac Troponin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bing W, Fraser IDC and Marston SB (1997) Troponin I and troponin T interact with troponin C to produce different Ca2+-dependant effects on actin—tropomyosin filament motility. Biochem J 327: 335–340.PubMedGoogle Scholar
  2. Bing W, Knott A and Marston S (2000a) A simple method for measuring the relative force exerted by myosin on actin filaments in the in vitro motility assay: evidence that tropomyosin and troponin increase force in single filaments. Biochem J 350: 693–699.PubMedCrossRefGoogle Scholar
  3. Bing W, Knott A, Redwood CS, Esposito G, Purcell I, Watkins S and Marston SB (2000b) Effect of hypertrophic cardiomyopathy mutations in human cardiac α-tropomyosin (Asp175Asn and Glu180Gly) on the regulatory properties of human cardiac troponin determined by in vitro motility assay. J Mol Cell Cardiol 32: 1489–1498.PubMedCrossRefGoogle Scholar
  4. Bing W, Razzaq A, Sparrow J and Marston S (1998) Tropomyosin and troponin regulation of wild type and E93K mutant actin filaments from Drososhila flight muscle. Charge reversal on actin changes actin—tropomyosin from on to off state. J Biol Chem 273: 15016–15021.PubMedCrossRefGoogle Scholar
  5. Bottinelli R, Coviello DA, Redwood CS, Pellegrino MA, Maron BJ, Spirito P, Watkins H and Reggiani C (1998) A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity. Circ Res 82: 106–115.PubMedGoogle Scholar
  6. Burton D, Abdulrazzak H, Knott A, Elliott K, Redwood CS, Watkins H, Marston S and Ashley C (2002) Two mutations in troponin I that cause hypertrophic cardiomyopathy have contrasting effects on cardiac muscle contractility. Biochem J 362: 443–451.PubMedCrossRefGoogle Scholar
  7. EL-Mezgueldi M (1996) Molecules in focus: calponin. Int J Biochem Cell Biol 28: 1185–1189.PubMedCrossRefGoogle Scholar
  8. EL-Mezgueldi M and Marston SB (1996) The effects of smooth muscle calponin on the strong and weak myosin binding sites on F-actin. J Biol Chem 271: 28161–28167.PubMedCrossRefGoogle Scholar
  9. Fraser IDC and Marston SB (1995a) In vitro motility analysis of actin—tropomyosin regulation by troponin and Ca2+: the thin filament is switched as a single cooperative unit. J Biol Chem 270: 7836–7841.PubMedCrossRefGoogle Scholar
  10. Fraser IDC and Marston SB (1995b) In vitro motility analysis of smooth muscle caldesmon control of actin—tropomyosin filament movement. J Biol Chem 270: 19688–19693.PubMedCrossRefGoogle Scholar
  11. Gordon AM, LaMadrid MA, Chen Y, Luo Z and Chase PB (1997) Calcium regulation of skeletal muscle thin filament motility in vitro. Biophys J 72: 1295–1307.PubMedGoogle Scholar
  12. Homsher E, Kim A, Bobkova A and Tobacman L (1996) Calcium regulation of thin filament movement in the in vitro motility assay. Biophys J 70: 1881–1892.PubMedGoogle Scholar
  13. Homsher E, Wang F and Sellers J (1993) Factors affecting filament velocity in in vitro motility assays and their relation to unloaded shortening velocity in muscle fibres. In: Sugi H and Pollack G (eds) Mechanism of Myofilament Sliding in Muscle Contraction. (pp. 279–290) Plenum Press, New York.Google Scholar
  14. Horiuchi KY and Chacko S (1995) Effect of unphosphorylated smooth muscle myosin on caldesmon-mediated regulation of actin filament velocity. J Muscle Res Cell Motil 16: 11–19.PubMedCrossRefGoogle Scholar
  15. Jungbluth H, Sewry CA, Brown SC, Nowak KJ, Laing NG, Wallgren-Pettersson C, Pelin K, Manzur AY, Mercuri E, Dubowitz V and Muntoni F (2001) Mild phenotype of nemaline myopathy with sleep hypoventilation due to a mutation in the skeletal muscle alpha-actin (ACTA1) gene. Neuromuscul Disord 11: 35–40.PubMedCrossRefGoogle Scholar
  16. Kamisago M, Sharma SD, DePalma SR, Solomon S, Sharma P, Smoot L, Mullen MP, Woolf PK, Wigle ED, Seidman JG, Seidman CE, Jarcho J and Shapiro LR (2000) Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med 343: 1688–1696.PubMedCrossRefGoogle Scholar
  17. Knott A, Purcell IF and Marston S (2002) In vitro motility analysis of thin filaments from failing and non-failing human hearts induces slower filament sliding and higher Ca2+-sensitivity. J Mol Cell Cardiol 34: 469–482.PubMedCrossRefGoogle Scholar
  18. Kron SJ and Spudich JA (1986) Fluorescent actin filaments move on myosin fixed to a glass surface. Proc Natl Acad Sci USA 83: 6272–6276.PubMedCrossRefGoogle Scholar
  19. Kron SJ, Toyoshima YY, Uyeda TQP and Spudich JA (1991) Assays for actin sliding movement over myosin coated surfaces. Meth. Enzymol 196: 399–416.PubMedGoogle Scholar
  20. Li D, Czernuszewicz GZ, Gonzalez O, Tapscott T, Karibe A, Durand JB, Brugada R, Hill R, Gregoritch JM, Anderson JL, Quinones M, Bachinski LL and Roberts R (2001) Novel cardiac troponin T mutation as a cause of familial dilated cardiomyopathy. Circulation 104: 2188–2193.PubMedGoogle Scholar
  21. Malnic B, Farah CS and Reinach FC (1998) Regulatory properties of the NH2-and COOH-terminal domains of troponin T. ATPase activation and binding to troponin I and troponin C. J Biol Chem 273: 10594–10601.PubMedCrossRefGoogle Scholar
  22. Marston S and Hodgkinson J (2001) NEWS and VIEWS: cardiac and skeletal myopathies: can genotype explain phenotype? J Muscle Res Cell Motil 22: 1–4.PubMedCrossRefGoogle Scholar
  23. Marston SB, Fraser IDC and Huber PAJ (1994) Smooth muscle caldesmon controls the strong binding interactions between actin—tropomyosin and myosin. J Biol Chem 269: 32104–32109.PubMedGoogle Scholar
  24. Marston SB, Fraser IDC, Wu B and Roper G (1996) A simple method for automatic tracking of actin filaments in the motility assay. J Muscle Res Cell Motil 17: 497–506.PubMedCrossRefGoogle Scholar
  25. Mirza M, Robinson P, Knott A, Watkins H, Redwood CS and Marston S (2002) Mutations in alpha tropomyosin associated with dilated cardiomyopathy alter contractility in reconstituted thin filaments. J Muscle Res Cell Motil 23: 32.Google Scholar
  26. Nowak KJ, Wattanasirichaigoon D, Goebel HH, Wilce M, Pelin K, Donner K, Jacob RL, Hubner C, Oexle K, Anderson JR, Verity CM, North KN, Iannaccone ST, Muller CR, Nurnberg P, Muntoni F, Sewry C, Hughes I, Sutphen R, Lacson AG, Swoboda KJ, Vigneron J, Wallgren-Pettersson C, Beggs AH and Laing NG (1999) Mutations in the skeletal muscle alpha-actin gene in patients with actin myopathy and nemaline myopathy. Nat Genet 23: 208–212.PubMedCrossRefGoogle Scholar
  27. Olson TM, Doan TP, Kishimoto NY, Whitby FG, Ackerman MJ and Fananapazir L (2000) Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy. J Mol Cell Cardiol 32: 1687–1694.PubMedCrossRefGoogle Scholar
  28. Olson TM, Kishimoto NY, Whitby FG and Michels VV (2001) Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy. J Mol Cell Cardiol 33: 723–732.PubMedCrossRefGoogle Scholar
  29. Pate E, Franks-Skiba K and Cooke R (1998) Depletion of phosphate in active muscle fibres probes actomyosin states within the powerstroke. Biophys J 74: 369–380.PubMedGoogle Scholar
  30. Potter JD, Sheng Z, Pan B and Zhao J (1995) A direct regulatory role for troponin T and a dual role for troponin C in the Ca2+ regulation of muscle contraction. J Biol Chem 270: 2557–2562.PubMedCrossRefGoogle Scholar
  31. Purcell IF, Bing W and Marston SB (1999) Functional analysis of human cardiac troponin by the in vitro motility assay: comparison of adult, foetal and failing hearts. Cardiovasc Res 43: 884–891.PubMedCrossRefGoogle Scholar
  32. Razzaq A, Schmitz S, Veigel C, Molloy JE, Geeves MA and Sparrow JC (1999) Actin residue glu(93) is identified as an amino acid affecting myosin binding. J Biol Chem 274: 28321–28328.PubMedCrossRefGoogle Scholar
  33. Redwood C, Lohmann K, Bing W, Esoposito G, Elliott K, Abdulrazzak H, Knott A, Purcell I, Marston S and Watkins H (2000) Investigation of a truncated troponin T that causes familial hypertrophic cardiomyopathy: Ca2+ regulatory properties of reconstituted thin filaments depend on the ratio of mutant to wild-type peptide. Circ Res 86: 1146–1152.PubMedGoogle Scholar
  34. Redwood CS, Moolman-Smook JC and Watkins H (1999) Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy. Cardiovasc Res 44: 20–36.PubMedCrossRefGoogle Scholar
  35. Redwood CS, Robinson P, Mirza M, Knott A, Marston S and Watkins H (2002) Mutations in human cardiac troponin T that cause dilated cardiomyopathy reduce thin filament activation and calcium sensitivity. J Muscle Res Cell Motil 23: 31.Google Scholar
  36. Robinson PJR, Mirza M, Knott A, Abdulrazzak H, Marston S, Watkins H and Redwood CS (2002) Alterations in thin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathy. J Biol Chem 277: 40710–40716.PubMedCrossRefGoogle Scholar
  37. Tardiff JC, Factor SM, Tompkins BD, Hewett TE, Palmer BM, Moore RL, Schwartz S, Robbins J and Leinwand LA (1998) A truncated troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy. J Clin Invest 101: 2800–2811.PubMedCrossRefGoogle Scholar
  38. Vilfan A (2001) The binding dynamics of tropomyosin on actin. Biophys J 81: 3146–3155.PubMedCrossRefGoogle Scholar
  39. Work SS and Warshaw DM (1992) Computer assisted tracking of actin filament motility. Anal Biochem 202: 275–285.PubMedCrossRefGoogle Scholar
  40. Wu B, Redwood CS, Purcell IF, Esposito G, Watkins H and Marston SB (1997) Effects of two hypertrophic cardiomyopathy mutations in α-tropomyosin, Asp175Asn and Glu180Gly, on Ca2+ regulation of thin filament motility. Biochem Biophys Res Commun 236: 760–764.CrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 2003

Authors and Affiliations

  • Steven Marston
    • 1
  1. 1.Imperial College London, t[NHLI Doverhouse StreetLondonUK; Tel.:

Personalised recommendations